JOURNAL OF ONCOLOGY PHARMACY PRACTICE, published by SAGE PUBLICATIONS LTD, is a pivotal resource in the fields of oncology, pharmacology, and medicine, with a dedicated focus on the evolving discipline of oncology pharmacy. Based in the United Kingdom, this journal has been diligently serving its readers since 1995 and continues to explore the intersection of pharmaceutical care and cancer treatment, showcasing innovative practices, research findings, and clinical advancements that are indispensable for healthcare professionals, researchers, and students alike. Although not an open-access journal, it holds a respectable Category Quartile Q3 ranking across its various fields, including Medicine, Oncology, and Pharmacology, indicating its relevance in nurturing academic discourse and addressing critical issues in cancer care. With an ISSN of 1078-1552 and E-ISSN of 1477-092X, the journal invites contributions that enhance the understanding of pharmaceutical interventions in oncology, aiming to improve therapeutic outcomes and patient care. Join a global community of professionals committed to excellence in oncology pharmacy practice and stay informed with cutting-edge research and reviews that significantly impact patient healthcare strategies.

Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.

SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.

FARMACIA HOSPITALARIA, published by Elsevier Science Inc, is a premier open access journal that has been contributing to the fields of Medicine and Pharmacology since its inception in 1990. Based in the Netherlands, this journal provides a vital platform for the dissemination of high-quality research related to hospital pharmacy practice, medication management, and therapeutic outcomes. With an impressive scope that bridges clinical and pharmaceutical sciences, it positions itself within the 3rd quartile of both Medicine (miscellaneous) and Pharmacology categories, showcasing its relevance and evolving contributions to healthcare discourse. Since adopting an open access model in 2005, FARMACIA HOSPITALARIA has committed to making its research widely available, facilitating knowledge sharing among professionals and academics alike. Researchers and practitioners looking to stay updated with the latest advancements in pharmacy and clinical practices will find this journal an indispensable resource.

Asian Journal of Pharmaceutical Research and Health Care, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating cutting-edge research in the fields of pharmacology, toxicology, and healthcare. With an ISSN of 2250-1444 and an E-ISSN of 2250-1460, this journal aims to provide valuable insights and advancements in pharmaceutical sciences, targeting researchers, practitioners, and students dedicated to improving health outcomes. Although its coverage in Scopus was discontinued in 2016, the journal maintains importance within the academic community by fostering discourse and sharing knowledge on emerging topics. Despite its challenges reflected in the low Scopus ranking within its category, the Asian Journal of Pharmaceutical Research and Health Care remains committed to enhancing access to critical research and publishing high-quality work that bridges the gap between theory and practice in health care. Researchers and professionals engaged in the pharmaceutical field are encouraged to contribute and leverage this journal as a means to advance their work and elevate healthcare standards in Asia and beyond.

JOURNAL OF PHARMACY PRACTICE AND RESEARCH is a pivotal platform dedicated to advancing knowledge and practice in the fields of pharmacy and pharmacology. Published by WILEY, this journal boasts a commendable impact factor, reflecting its contribution to the scientific community. With an ISSN of 1445-937X and E-ISSN 2055-2335, it emphasizes high-quality, peer-reviewed research essential for pharmacists, healthcare professionals, and researchers. Operating without an open-access model, it currently holds a Q3 ranking in Pharmacology and a Q2 ranking in Pharmacy according to the 2023 category quartiles, positioning it as a key resource for evidence-based practices and recent innovations in the pharmaceutical sciences. The journal spans from 2002 to 2024 and is recognized for enhancing the dialogue between academia and clinical practice. It provides a vital portal for exploring contemporary research trends and addressing pressing challenges in pharmacy practice, making it an indispensable resource for advancing professional development and improving patient care.

Canadian Journal of Hospital Pharmacy, published by the Canadian Society of Hospital Pharmacists, stands as a pivotal resource within the field of pharmacy and medical pharmacology since its inception in 1973. With its ISSN 0008-4123, this peer-reviewed journal aims to advance the knowledge and practice of hospital pharmacy through the dissemination of high-quality research, reviews, and case studies. Although currently not an open-access journal, it boasts a respectable influence in the academic community, reflected in its Q3 quartile rankings in both pharmacology and pharmacy as of 2023. Located in Ottawa, Canada, the journal encourages contributions that emphasize evidence-based practices and innovative solutions to enhance patient care. By fostering a dialogue among pharmacists, researchers, and healthcare professionals, the Canadian Journal of Hospital Pharmacy continues to be an essential platform for addressing contemporary issues and advancements in the hospital pharmacy landscape.

Actualites Pharmaceutiques, published by Elsevier Masson, is a prominent French journal in the field of pharmacology, offering insights into the latest developments within medical pharmacology. Established in 1961, this journal has been a vital resource for researchers and professionals aiming to explore contemporary issues and advancements within the pharmacological landscape. With an **impact factor** that reflects its standing in the academic community, Actualites Pharmaceutiques is classified in the Q4 quartile, indicating its niche but steady contribution to the discipline. Although it operates under a traditional subscription model, it serves as a platform for both emerging and established scientists. Despite its current Scopus rankings placing it in the lower percentiles within its category, the journal remains dedicated to fostering research excellence and disseminating innovative findings that contribute to the safety and efficacy of pharmacological practices. The journal notably merges historical insights with cutting-edge research avenues, making it an invaluable asset for anyone committed to advancing their knowledge in pharmacology.